Core Lithium shares: where next after solid FY23 results?
Core Lithium shares rocketed 26% higher on earnings day but have now fallen flat. Is this an opportunity, or is further downside ahead?
Core Lithium (ASX: CXO) shares shot up by 26% to $0.43 last week after releasing strong full year results that investors hoped might spell the end of its share price woes.
For context, the ASX lithium stock — despite remaining over 700% higher than pre-pandemic levels — has now lost more than two-thirds of its value year-to-date. This reflects the falling lithium price and relatively bearish sentiment in the sector.
And disappointingly, CXO shares have fallen back to $0.34, the same price point prior to the results. However, this retracement could be due to wider macro concerns regarding the lithium pricing outlook.
Core Lithium shares: full-year results
FY23 results were received positively as the company announced a maiden profit. Revenue came in at $50.6 million, resulting in a net profit on $10.8 million — though this was boosted by a $1.6 million deferred tax benefit.
CXO sold 5,423 tonnes of spodumene concentrate at an average realised sales price of US$4,163 per tonne — and it also sold 14,774 tonnes of Direct Shipping Ore at US$951 per tonne from Finniss. Core Lithium saw C1 costs of $1,230 per tonne, leaving EBITDA at $14 million, and operating cash flow at $90.8 million.
The company held $153 million in cash at the end of the financial year, and crucially in this tightening monetary environment, also ended the year with no debt. And this figure doesn’t include either its $111.4 million raising or sales made after the reporting date — a further 23,100 tonnes of spodumene concentrate and 15,000 tonnes of lithium fines.
Where next for Core Lithium shares?
During the financial year, flagship Finniss saw its Mineral Resource Estimate increased by 62% to 30.6Mt @ 1.31% Li2O, including the BP33 Mineral Resource estimate of 10.1Mt @ 1.48% Li2O. Over the longer-term, this hugely improves the company’s business case.
CEO Gareth Manderson enthuses that ‘early works and the updated feasibility study at BP33, Finniss’ potential cornerstone asset, are progressing well and the project is on track for FID in the March quarter…our strategy to drive long-term shareholder value is unchanged – ramp up Grants production and deliver spodumene concentrate into long-term offtake agreements, grow the broader Finniss district mine life.’
Indeed, the company has already reaffirmed production guidance of 80,000 to 90,000 tonnes, and sales of 90,000 to 100,000 tonnes of spodumene concentrate, with C1 costs of $1,165 to $1,250 a tonne.
On the other hand, Core Lithium still has a potential lawsuit from Tesla to face down after the breakdown of a 2022 supply agreement — for 110,000 tonnes of spodumene concentrate. And the stock remains one of the most shorted on the ASX, despite the ongoing negotiations.
This week, JP Morgan downgraded the entire lithium sector after a review of lithium prices — with analyst Lyndon Fagan noting that ‘It is hard to build conviction on a near-term sector recovery, and therefore we rank the lithium space behind base & bulk commodities on a relative view.’ UBS is also bearish on the sector.
Further, a note from Citi predicted that prices may continue to fall by up to 20%, even after the 2023 correction. Citi cut Core Lithium and IGO to underweight, and Pilbara Minerals to neutral, leaving Allkem and Leo Lithium as overweight.
Conversely, Macquarie remains bullish on both lithium and lithium producers, seeing the current weakness as creating significant potential buying opportunities. It has an outperform rating on Core Lithium and a 12-month share price target of $0.65 — nearly double the current price.
It’s worth noting the continued merger and acquisition activity in the space. Allkem and Livent’s multi-billion-dollar tie-up. The Albemarle and Liontown merger, and Gina Rinehart’s involvement. Mineral Resources and its increasing stake in Delta Lithium.
While investment banks typically work on a 12-month basis, long-term investors need to balance any potential short-term weakness with the anticipated supply gap over the longer term. There is a finite supply of quality lithium producers.
As Core Lithium is now profitable and has no debt, it may even become a takeover target. But if not, its massively increased mineral resource stands it in good stead — and the current share price may now be looking attractive.
Of course, there may be further to fall.
Past performance is not an indicator of future returns.
Take your position on over 13,000 local and international shares via CFDs or share trading – all at your fingertips on our award-winning platform.*
Winner of ‘Best Multi-Platform Provider’ at ADVFN International Finance Awards 2022
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets